Association of VEGFA, TIMP-3, and IL-6 gene polymorphisms with predisposition to optic neuritis and optic neuritis with multiple sclerosis

References

• Pau D, Al Zubidi N, Yalamanchili S, Plant GT, Lee AG. Optic neuritis. Eye (Lond). 2011 Jul;25(7):833–42. doi:10.1038/eye.2011.81.
   PubMed Web of Science ®Google Scholar
• Torben LS, Frederiksen JL, Ransohoff RM.Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest. 1999;103(6):807–15.doi:10.1172/JCI5150.
   PubMed Web of Science ®Google Scholar
• Horton S, MacDonald DJ, Erickson K.MS, exercise, and the potential for older adults. Eur Rev Aging Phys Act. 2010;7(1):49.doi:10.1007/s11556-010-0062-9.
   Web of Science ®Google Scholar
• Wilhelm H, Schabet M. The diagnosis and treatment of optic neuritis. Dtsch Arztebl Int. 2015 Sep;112(37):616–25;quiz 626. doi: 10.3238/arztebl.2015.0616.
   Google Scholar
• Toosy AT, Mason DF, Miller DH. Optic neuritis. Lancet Neurol. 2014 Jan;13(1):83–99. doi:10.1016/S1474-4422(13)70259-X.
   PubMed Web of Science ®Google Scholar
• Ascherio A, Munger KL.Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol. 2007;61(4):288–99.doi:10.1002/ana.21117.
   PubMed Web of Science ®Google Scholar
• Ascherio A, Munger KL.Environmental risk factors for multiple sclerosis. Part II: noninfectious factors. Ann Neurol. 2007;61(6):504–13.doi:10.1002/ana.21141.
   PubMed Web of Science ®Google Scholar
• Voss E, Raab P, Trebst C, Stangel M.Clinical approach to optic neuritis: pitfalls, red flags and differential diagnosis. Ther Adv Neurol Disord. 2011;4(2):123–34.doi:10.1177/1756285611398702.
   PubMedGoogle Scholar
• Petković F, Castellano B. The role of interleukin-6 in central nervous system demyelination. Neural Regen Res. 2016 Dec;11(12):1922–23. doi:10.4103/1673-5374.195273.
   PubMed Web of Science ®Google Scholar
• Kirk SL, Karlik SJ. VEGF and vascular changes in chronic neuroinflammation. J Autoimmun. 2003 Dec;21(4):353–63. doi:10.1016/S0896-8411(03)00139-2.
   PubMed Web of Science ®Google Scholar
• Nuttall RK, Silva C, Hader W, Bar-Or A, Patel KD, Edwards DR, Yong VW.Metalloproteinases are enriched in microglia compared with leukocytes and they regulate cytokine levels in activated microglia. Glia. 2007;55(5):516–26.doi:10.1002/glia.20478.
   PubMed Web of Science ®Google Scholar
• Ataie-Kachoie P, Pourgholami MH, Richardson DR, Morris DL. Gene of the month: interleukin 6 (IL-6). J Clin Pathol. 2014 Nov;67(11):932–37. doi:10.1136/jclinpath-2014-202493.
   PubMed Web of Science ®Google Scholar
• Peng X, Shi J, Sun W, Ruan X, Guo Y, Zhao L, Wang J, Li B. Genetic polymorphisms of IL-6 promoter in cancer susceptibility and prognosis: a meta-analysis. Oncotarget. 2018 Feb 23;9(15):12351–64. doi: 10.18632/oncotarget.24033.
   PubMedGoogle Scholar
• González-Castro T, Hernández-Díaz Y, Pérez-Hernández N, Tovilla-Zárate C, Juárez-Rojop I, López-Narvaez M, Blachman-Braun R, Posadas-Sánchez R, Vargas-Alarcón G, García-Flores E, et al. Interleukin 6 (rs1800795) gene polymorphism is associated with cardiovascular diseases: a meta-analysis of 74 studies with 86,229 subjects. Excli J. 2019;18:331–55.
   PubMed Web of Science ®Google Scholar
• Tammela T, Petrova TV, Alitalo K.Molecular lymphangiogenesis: new players. Trends Cell Biol. 2005;15(8):434–41.doi:10.1016/j.tcb.2005.06.004.
   PubMed Web of Science ®Google Scholar
• Argaw AT, Gurfein BT, Zhang Y, Zameer A, John GR.VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown. Proc Natl Acad Sci U S A. 2009;106(6):1977–82.doi:10.1073/pnas.0808698106.
   PubMed Web of Science ®Google Scholar
• Wang Y, Huang Q, Liu J, Wang Y, Zheng G, Lin L, Yu H, Tang W, Huang Z. Vascular endothelial growth factor A polymorphisms are associated with increased risk of coronary heart disease: a meta-analysis. Oncotarget. 2017 May 2;8(18):30539–51. doi: 10.18632/oncotarget.15546.
   PubMedGoogle Scholar
• Fang A, Lee A, Kulkarni M, Osborn M, Brantley JM. Polymorphisms in the VEGFA and VEGFR-2 genes and neovascular age-related macular degeneration. Mol Vis. 2009;15:2710–19.
   PubMed Web of Science ®Google Scholar
• Das AM, Bolkestein M, van der Klok T, Oude OCM, Vermeulen CE, Rens JA, Dinjens WN, Atmodimedjo PN, Verhoef C, Koljenović S, et al. Progression and inhibits melanoma cell migration. Eur J Cancer. 2016 Oct;66:34–46. doi:10.1016/j.ejca.2016.06.020.
   PubMed Web of Science ®Google Scholar
• Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature. 1997 Feb 20;385(6618):729–33. doi: 10.1038/385729a0.
   PubMed Web of Science ®Google Scholar
• Khokha R, Murthy A, Weiss A. Metalloproteinases and their natural inhibitors in inflammation and immunity. Nat Rev Immunol. 2013 Sep;13(9):649–65. doi:10.1038/nri3499.
   PubMed Web of Science ®Google Scholar
• Optic Neuritis Study Group The clinical profile of optic neuritis. Experience of the optic neuritis treatment trial. Arch. Ophthalmol. 1991;109:1673–88. doi:10.1001/archopht.1991.01080120057025.
   PubMedGoogle Scholar
• Gerwien H, Hermann S, Zhang X, Korpos E, Song J, Kopka K, Faust A, Wenning C, Gross CC, Honold L, et al. Imaging matrix metalloproteinase activity in multiple sclerosis as a specific marker of leukocyte penetration of the blood-brain barrier. Sci Transl Med. 2016 Nov 9;8(364):364ra152. doi: 10.1126/scitranslmed.aaf8020.
   PubMed Web of Science ®Google Scholar
• Su C, Huang Y, Chen M, Su S, Yang S, Lin C. Polymorphisms and Plasma Levels of Tissue Inhibitor of Metalloproteinase-3: impact on Genetic Susceptibility and Clinical Outcome of Oral Cancer. Medicine (Baltimore). 2015 Nov;94(46):e2092. doi:10.1097/MD.0000000000002092.
   PubMed Web of Science ®Google Scholar
• Peterson NB, Beeghly-Fadiel A, Gao Y-T, Long J, Cai Q, Shu X-O, Zheng W. Polymorphisms in tissue inhibitors of metalloproteinases-2 and −3 and breast cancer susceptibility and survival. Int J Cancer. 2009 Aug 15;125(4):844–50. doi: 10.1002/ijc.24405.
   PubMed Web of Science ®Google Scholar
• Dooley MC, Foroozan R.Optic neuritis. J Ophthalmic Vis Res. 2010;5(3):182–87.
   PubMedGoogle Scholar
• Shams PN, Plant GT.Optic neuritis: a review. Int MS J. 2009;16(3):82–89.
   PubMedGoogle Scholar
• Li J, Tripathi RC, Tripathi BJ.Drug-induced ocular disorders. Drug Saf. 2008;31(2):127–41.doi:10.2165/00002018-200831020-00003.
   PubMed Web of Science ®Google Scholar
• McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50(1):121–27.doi:10.1002/ana.1032.
   PubMed Web of Science ®Google Scholar
• Liutkevičienė R, Vilkevičiūtė A, Banevičus M, Miežytė R, Kriaučiūnienė L. Association of MMP-2 (⁻1306 C/T) gene polymorphism with predisposition to optic neuritis and optic neuritis together with multiple sclerosis. Medicina (Kaunas). 2018;54:2.
   Web of Science ®Google Scholar
• Banevicius M, Vilkeviciute A, Glebauskiene B, Kriauciuniene L, Liutkeviciene R. Association of optic neuritis with CYP4F2 gene single nucleotide polymorphism and IL-17A concentration. J Ophthalmol. 2018 Mar 15;2018:1686297. doi:10.1155/2018/1686297.
   PubMed Web of Science ®Google Scholar
• Gedvilaite G, Vilkeviciute A, Kriauciuniene L, Asmoniene V, Does LR. CETP rs5882, rs708272, SIRT1 rs12778366, FGFR2 rs2981582, STAT3 rs744166, VEGFA rs833068, IL6 rs1800795 polymorphisms play a role in optic neuritis development? Ophthalmic Genet. 2019 Jun;40(3):219–26.
   PubMed Web of Science ®Google Scholar
• Pasqualetti G, Danesi R, Del Tacca M, Bocci G.Bascular endothelial growth factor pharmacogenetics: a new perspective for anti-angiogenic therapy. Pharmacogenomics. 2007;8(1):49–66.doi:10.2217/14622416.8.1.49.
   PubMed Web of Science ®Google Scholar
• Harper SJ, Bates DO.VEGF-A splicing: the key to anti-angiogenic therapeutics? Nat Rev Cancer. 2008;8(11):880–87.doi:10.1038/nrc2505.
   PubMed Web of Science ®Google Scholar
• Ardeljan D, Meyerle CB, Agron E, Jin Wang J, Mitchell P, Chew EY, Zhao J, Maminishkis A, Chan -C-C, Tuo J, et al. Influence of TIMP3/SYN3 polymorphisms on the phenotypic presentation of age-related macular degeneration. Eur J Hum Genet. 2013;21(10):1152–57.doi:10.1038/ejhg.2013.14.
   PubMed Web of Science ®Google Scholar
• Wang W, Chen J, Zhao F, Zhang B, Yu H.Lack of association between a functional polymorphism (rs1800796) in the interleukin-6 gene promoter and lung cancer. Diagn Pathol. 2014;9(1):134.doi:10.1186/1746-1596-9-134.
   PubMed Web of Science ®Google Scholar
• Konwar C, Del Gobbo GF, Terry J, Robinson WP.Association of a placental Interleukin-6 genetic variant (rs1800796) with DNA methylation, gene expression and risk of acute chorioamnionitis. BMC Med Genet. 2019;20(1):36.doi:10.1186/s12881-019-0768-0.
   PubMed Web of Science ®Google Scholar
• Huang C, Xu Y, Li X, Wang W. Vascular endothelial growth factor A polymorphisms and age-related macular degeneration: a systematic review and meta-analysis. Mol Vis. 2013 Jun;2(19):1211–21.
   Google Scholar
• Saxena M, Agrawal C, Srivastava N, Banerjee M. Interleukin-6 (IL-6)-597 A/G (rs1800797) & −174 G/C (rs1800795) gene polymorphisms in type 2 diabetes. Indian J Med Res. 2014 Jul;140(1):60–68.
   PubMed Web of Science ®Google Scholar
• Amr K, El-Awady R, Raslan H. Assessment of the −174G/C (rs1800795) and −572G/C (rs1800796) interleukin 6 gene polymorphisms in egyptian patients with rheumatoid arthritis. Open Access Maced J Med Sci. 2016 Dec 15;4(4):574–77. doi: 10.3889/oamjms.2016.110.
   PubMedGoogle Scholar
• Leibinger M, Müller A, Gobrecht P, Diekmann H, Andreadaki A, Fischer D. Interleukin-6 contributes to CNS axon regeneration upon inflammatory stimulation. Cell Death Dis. 2013 Apr 25;4(4):e609. doi: 10.1038/cddis.2013.126.
   PubMed Web of Science ®Google Scholar
• Ewald L, Beate LW, Stephanie S, Wilfried R, Yosuf E-S. Analysis of a functional IL-6 gene polymorphism in HLAB27 associated and intermediate uveitis gives new insight in disease pathogenesis and commonality with other autoimmune diseases. J Immunol Res. 2015;2015:174062. doi:10.1155/2015/174062.
   PubMed Web of Science ®Google Scholar
• Das A, Guyton MK, Smith A, Wallace G 4th, McDowell ML, Matzelle DD, Ray SK, Banik NL. Calpain inhibitor attenuated optic nerve damage in acute optic neuritis in rats. J Neurochem. 2013 Jan;124(1):133–46. doi:10.1111/jnc.12064.
   PubMed Web of Science ®Google Scholar
• Mandler RN, Dencoff JD, Midani F, Ford CC, Ahmed W, Rosenberg GA. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in cerebrospinal fluid differ in multiple sclerosis and Devic’s neuromyelitis optica. Brain. 2001 Mar;124(Pt 3):493–98. doi:10.1093/brain/124.3.493.
   PubMed Web of Science ®Google Scholar
• Jaworski DM, Fager N. Regulation of tissue inhibitor of metalloproteinase-3 (TIMP-3) mRNA expression during rat CNS development. J Neurosci Res. 2000;6:396–408.
   Web of Science ®Google Scholar
• Vaillant C, Didier-Bazes M, Hutter A, Belin MF, Thomasset N. Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum. J Neurosci. 1999;19:4994–5004.doi:10.1523/JNEUROSCI.19-12-04994.1999.
   PubMed Web of Science ®Google Scholar
• Su JJ, Osoegawa M, Matsuoka T, Minohara M, Tanaka M, Ishizu T, Mihara F, Taniwaki T, Kira J. Upregulation of vascular growth factors in multiple sclerosis: correlation with MRI findings. J Neurol Sci. 2006 Apr 15;243(1–2):21–30. doi: 10.1016/j.jns.2005.11.006.
   PubMed Web of Science ®Google Scholar
• Argaw AT, Zhang Y, Snyder BJ, Zhao ML, Kopp N, Lee SC, Raine CS, Brosnan CF, John GR. IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program. J Immunol. 2006;177:5574–84. doi: 10.4049/jimmunol.177.8.5574.
   PubMed Web of Science ®Google Scholar
• Proescholdt MA, Jacobson S, Tresseler N.Vascular endothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats. J Neuropath Exp Neurol. 2002;61(10):914–25.doi:10.1093/jnen/61.10.914.
   PubMed Web of Science ®Google Scholar
• Lambalgen RV, Sanders EACM, D’Amaro J.Sex distribution, age of onset and HLA profiles in two types of multiple sclerosis. A role of sex hormones and microbial differences infections in the development of autoimmunity? J Neurol Sci. 1986;76(1):13–21.doi:10.1016/0022-510X(86)90138-3.
   PubMed Web of Science ®Google Scholar
• Fukazawa T, Yamasaki K, Ito H, Kikuchi S, Minohara M, Horiuchi I, Tsukishima E, Sasaki E, Hamada T, Nishimura Y, et al. Both the HLA-CPB1 and -DRB1 alleles correlate with risk for multiple sclerosis in Japanese: clinical phenotypes and gender as important factors Tissue Antigens. 2000 Mar;55(3):199–205. doi: 10.1034/j.1399-0039.2000.550302.x.
   Google Scholar
• Schuurs A, Verheul H. Effects of gender et al. Major Histocompatibility Complex and Sex Steroids on the Immune Response. J Between Susceptibility to Multiple Sclerosis Class II Alleles and the Course and Outcome Steroid Biochem. 1990;35:157–72.
   Google Scholar